Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6151–6200 of 34715
At the Effective Time, pursuant to the Merger Agreement, Mark First, Allan Hall, Scott Huff, Kimberly Lefko, Sheryl O’Loughlin and Kenneth Walker, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
At the Effective Time, pursuant to the Merger Agreement, Mark First, Allan Hall, Scott Huff, Kimberly Lefko, Sheryl O’Loughlin and Kenneth Walker, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
On October 21, 2024, Charles C. Van Vleet, Jr. notified the Boards of Directors of Gouverneur Bancorp, Inc. (the “Company”) and Gouverneur Savings and Loan Association (the “Bank”) that he intends to retire as a director of the Company and the Bank effective as of December 31, 2024.
On October 23, 2024, the Board of Directors (the “Board”) of the Company increased the number of directors on the Board from six to seven and appointed David Jin as a new member of the Board.
On October 21, 2024, in connection with the IPO, Jonathan S. Marshall, Stuart Kovensky, Meltem Demirors, and Peter Early (the “ New Directors ” and, collectively with Robert I. Kauffman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On October 21, 2024, in connection with the IPO, Jonathan S. Marshall, Stuart Kovensky, Meltem Demirors, and Peter Early (the “ New Directors ” and, collectively with Robert I. Kauffman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On October 21, 2024, in connection with the IPO, Jonathan S. Marshall, Stuart Kovensky, Meltem Demirors, and Peter Early (the “ New Directors ” and, collectively with Robert I. Kauffman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On October 21, 2024, in connection with the IPO, Jonathan S. Marshall, Stuart Kovensky, Meltem Demirors, and Peter Early (the “ New Directors ” and, collectively with Robert I. Kauffman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On October 24, 2024, Siddarth Subramony, Ph.D. resigned from the Board of Directors (the Board) of Tyra Biosciences, Inc. (Tyra or the Company) and the Compensation Committee of the Board (the Compensation Committee) effective immediately.
On October 24, 2024, Mr. Peter Schoels notified New York Community Bancorp, Inc. (the “Company”) of his resignation as a member of the Board of Directors of the Company and the Board of Directors of Flagstar Bank, N.A., a wholly owned subsidiary of the Company, effective October 25, 2024.
On October 23, 2024, in connection with the IPO, Diarmuid Cummins, Amy Gershkoff Bolles, Jason Park, Anna Marie Wagner and Simon Watson were appointed to the board of directors of the Company (the “Board”).
On October 23, 2024, in connection with the IPO, Diarmuid Cummins, Amy Gershkoff Bolles, Jason Park, Anna Marie Wagner and Simon Watson were appointed to the board of directors of the Company (the “Board”).
On October 23, 2024, in connection with the IPO, Diarmuid Cummins, Amy Gershkoff Bolles, Jason Park, Anna Marie Wagner and Simon Watson were appointed to the board of directors of the Company (the “Board”).
On October 23, 2024, in connection with the IPO, Diarmuid Cummins, Amy Gershkoff Bolles, Jason Park, Anna Marie Wagner and Simon Watson were appointed to the board of directors of the Company (the “Board”).
On October 23, 2024, in connection with the IPO, Diarmuid Cummins, Amy Gershkoff Bolles, Jason Park, Anna Marie Wagner and Simon Watson were appointed to the board of directors of the Company (the “Board”).
The Board declared Gregg C. Tumeinski , executive vice president and chief financial officer of The Beacon Mutual Insurance Company in Warwick, Rhode Island, elected to fill a member directorship designated for the State of Rhode Island.
• Antoinette C. Lazarus, regulatory, compliance, and risk executive in Hartford, Connecticut.
• Thomas J. Curry, retired law partner and bank regulator in Osterville, Massachusetts;
On October 21, 2024, Director Gordon Woods announced his retirement and tendered his resignation as a director of Sierra Bancorp (the “Company”) (Nasdaq: BSRR) and the Company’s wholly owned subsidiary, Bank of the Sierra, effective immediately.
On October 23, 2024, the Board of Directors (the “Board”) of Berry Corporation (bry) (the “Company”) appointed Matthew Bob to fill the current vacancy on the Board, effective the same day.
Effective October 24, 2024, Patrick McNamee resigned from the board of directors (the “Board”) of LuxUrban Hotels Inc. (the “Company”).
Effective October 25, 2024, Dr. K. Brad Stamm will retire from the Board of Directors of the Company and the Bank
named Kevin G. Frey to fill a vacancy created by the retirement of Dr. K. Brad Stamm
On October 22, 2024, the Board of Directors (the Board) of Trustmark Corporation (Trustmark) voted to appoint Lea B. Turnipseed, age 52, to the Board effective January 1, 2025.
Effective October 31, 2024, Bill Rupp (“BR”) will step down as a member of the Board of Directors of the Company but will continue in his role on the Company’s Advisory Board.
As previously disclosed, on August 1, 2024, the Board elected Adam Stewart as a director, contingent and effective immediately upon the resignation described above.
On October 18, 2024, Tom Ehrhart notified Vivid Seats Inc. (the “ Company ”) of his resignation from the Company’s Board of Directors (the “ Board ”), effective November 1, 2024.
On October 22, 2024, the Board of Directors (the “Board”) of Radius Recycling, Inc. (the “Company”) determined to increase the number of authorized directors from seven to eight and elect Mauro Gregorio to serve as a Class III director, effective November 1, 2024.
David W. Biegler, J. Veronica Biggins, Roy Blunt, William H. Cunningham, Thomas W. Gilligan, and Jill A. Soltau each submitted his or her resignation from the Board, effective 11:59 p.m. Central Time on November 1, 2024.
the Board appointed Pierre Breber as a member of the Board, effective 11:59 p.m. Central Time on November 1, 2024
David W. Biegler, J. Veronica Biggins, Roy Blunt, William H. Cunningham, Thomas W. Gilligan, and Jill A. Soltau each submitted his or her resignation from the Board, effective 11:59 p.m. Central Time on November 1, 2024.
David W. Biegler, J. Veronica Biggins, Roy Blunt, William H. Cunningham, Thomas W. Gilligan, and Jill A. Soltau each submitted his or her resignation from the Board, effective 11:59 p.m. Central Time on November 1, 2024.
David W. Biegler, J. Veronica Biggins, Roy Blunt, William H. Cunningham, Thomas W. Gilligan, and Jill A. Soltau each submitted his or her resignation from the Board, effective 11:59 p.m. Central Time on November 1, 2024.
David W. Biegler, J. Veronica Biggins, Roy Blunt, William H. Cunningham, Thomas W. Gilligan, and Jill A. Soltau each submitted his or her resignation from the Board, effective 11:59 p.m. Central Time on November 1, 2024.
David W. Biegler, J. Veronica Biggins, Roy Blunt, William H. Cunningham, Thomas W. Gilligan, and Jill A. Soltau each submitted his or her resignation from the Board, effective 11:59 p.m. Central Time on November 1, 2024.
On October 21, 2024, the Board of Directors (the “Board”) of Guardant Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed Roberto Mignone., as a Class I director of the Company, to be effective as of October 21, 2024.
On October 19, 2024, Joerg Mosolf resigned as a director of Spectaire Holdings Inc. (the “Company”) and Brian Hemond resigned as a director and executive officer of the Company.
On October 24, 2024, TFS Financial Corporation (the "Company") appointed Terrence L. Bauer to fill the vacant board position created by the Bylaw amendment described below.
On May 17, 2024, Austin McDonald was appointed as a director of the Company;
On September 1, 2024, Clif Saylor resigned as a director of the Company for personal reasons.
he was subsequently reappointed as a director of the Company on October 10, 2024
the Board received and accepted the resignation of Hongbo Li from his position as a director of the Board.
the Board appointed Mengshu Shao, effective October 23, 2024, to the Board to fill the director vacancy left by Mr. Tianwei Li.
the Board appointed Yongbo Mo, effective October 23, 2024, to the Board to fill the independent director vacancy left by Mr. Hongbo Li.
the Board of Directors (the “Board”) of Inno Holdings Inc. (the “Company”) received and accepted the resignation of Tianwei Li from his position as a director of the Board.
On October 21, 2024, the board of directors of Reed’s, Inc., a Delaware corporation (“Reed’s”), upon recommendation from its governance committee, appointed Sam Van to serve as a member of its board of directors, to fill an existing vacancy, until his successor is elected and qualified, or until he resigns or is removed.
On October 18, 2024, the Company appointed Ms. Linda Graebner as a Director of the Company.
the board of directors (the “Board”) of the Company, on the recommendation of its Nominating and Corporate Governance Committee, unanimously authorized the increase in the size of the Board from seven to eight directors, and, to fill the resulting vacancy, appointed Mark Ross to serve as a Class III director, effective immediately.
Effective October 23, 2024, the Board of Directors (the “Board”) of Humana Inc. (the “Company”) expanded its number of authorized directors from eleven to twelve and elected Gordon Smith as a director of the Company.
the Board appointed Mr. Zongmin (Philip) Ding as a Class A director of the Board, effective upon closing of the Transaction
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.